Критерії відбору пацієнтів до реваскуляризації та інших видів хірургічної корекції при ішемічній кардіоміопатії

Н.Д. Орищин

Література

1. Aklog L, Filsoufi F, Flores K.Q, et al. Does coronary artery bypass grafting alone correct moderate ischemic mitral regurgitation? Circulation. 2001;104:168-175.
2. Afridi I, Kleiman NS, Raizner AE, Zoghbi WA. Dobutamine echocardiography in myocardial hibernation: optimal dose and accuracy in predicting recovery of ventricular function after coronary angioplasty. Circulation. 1995;91:663-670.
3. Allman KC, Shaw LJ, Hachamovitch R, Udelson JE. Myocardial viability testing and impact of revascularization on prognosis in patients with coronary artery disease and left ventricular dysfunction: a meta-analysis. J Amer Coll Cardiology. 2002;39:1151-1158.
4. Athanasuleas CL, Buckberg G.D, Stanley AW, et al. Surgical ventricular restoration: the RESTORE Group experience. Heart Fail Rev. 2004;9:287-297.
5. Baker DW, Jones R, Hodges J, et al. Management of heart failure. III. The role of revascularization in the treatment of patients with moderate or severe left ventricular systolic dysfunction. JAMA. 1994;272:1528-1534.
6. Baer FM, Voth E, Schneider CA, et al. Comparison of low-dose dobutamine gradient-echo magnetic resonance imaging and positron emission tomography with [18F] fluorodeoxyglucose in patients with chronic coronary artery disease. A functional and morphological approach to the detection of residual myocardial viability. Circulation. 1995;91:1006-1015.
7. Bax JJ, Wijns W, Cornel JH. Accuracy of currently available techniques for prediction of functional recovery after revascularization in patients with left ventricular dysfunction due to chronic coronary artery disease: comparison of pooled data. J. Amer Coll Cardiology. 1997;30:1451-1460.
8. Bax JJ, Poldermans D, Elhendy A, et al. Sensitivity, specificity, and predictive accuracies of various noninvasive techniques for detecting hibernating myocardium. Curr Probl Cardiol. 2001;26:147-186.
9. Bax JJ, Schinkel AF, Boersma E, et al. Extensive left ventricular remodeling does not allow viable myocardium to improve in left ventricular ejection fraction after revascularization and is associated with worse long-term prognosis.. Circulation. 2004;110:18-22.
10. Bax JJ, van der Wall EE, Harbinson M. Radionuclide techniques for the assessment of myocardial viability and hibernation. Heart. 2004;90(V):26-33.
11. Beanlands TD, Ruddy RA, de Kamp et al. Positron emission tomography and recovery following revascularization: the importance of scar and the development of a prediction rule for the degree of recovery of left ventricular function. J Am Coll Cardiol. 2002;40:1735-1743.
12. Beanlands RS, Chow BJ, Dick A. CCS/CAR/CANM/CNCS/CanSCMR joint position statement on advanced noninvasive cardiac imaging using positron emission tomography, magnetic resonance imaging and multidetector computed tomographic angiography in the diagnosis and evaluation of ischemic heart disease - executive summary. Can J Cardiol. 2007;23:107-119.
13. Beek AM, Kuhl HP, Bondarenko O, et al. Delayed contrast-enhanced magnetic resonance imaging for the prediction of regional functional improvement after acute myocardial infarction. J Am Coll Cardiol. 2003;42:895-901.
14. Benedetto U, Melina G, et al. Does combined mitral valve surgery improve survival when compared to revascularization alone in patients with ischemic mitral regurgitation? A meta-analysis on 2479 patients. J Cardiovasc. Med. 2009;10 (2):109-114.
15. Bonow RO, Maurer G, Lee Kerry L, Holly TA. Myocardial viability and survival in ischemic left ventricular dysfunction. New Engl J Med. 2011;364:1617-1625.
16. Braunwald E, Kloner RA. The stunned myocardium: prolonged, postischemic ventricular dysfunction. Circulation. 1982;66:1146-1149.
17. Buckberg GD. Form versus disease: optimizing geometry during ventricular restoration. Eur. J. Cardiothorac. Surg. 2006;29:238-244.
18. Bursi F, Enriquez-Sarano M, Nkomo VT, et al. Heart failure and death after myocardial infarction in the community: the emerging role of mitral regurgitation. Circulation. 2005;111:295-301.
19. Calafiore AM, Iacò AL, Amata D, et al. Left ventricular surgical restoration for anteroseptal scars: volume versus shape. J Thorac Cardiovasc Surg. 2010;139 (5):1123-1130.
20. Di Carli MF, Maddahi J, Rokhsar S, et al. Long-term survival of patients with coronary artery disease and left ventricular dysfunction: implications for the role of myocardial viability assessment in management decisions. J Thorac Cardiovasc Surg. 1998;116:997-1004.
21. Carluccio E, Biagioli P, Alunni G, et al. Patients with hibernating myocardium show altered left ventricular volumes and shape, which revert after revascularization: evidence that dyssynergy might directly induce cardiac remodeling. J Am Coll Cardiol. 2006;47:969-977.
22. Chua T. Myocardial viability: strengthening the evidence base. Eur J Nucl Med Mol Imag. 2008;5:2035-2037.
23. Deja MA, Grayburn PA, Sun B, et al. Influence of mitral regurgitation repair on survival in the surgical treatment for ischemic heart failure trial. Circulation. 2012;125:2639-2648.
24. Di Donato M, Sabatier M, Dor V, et al. Effects of the Dor procedure on left ventricular dimension and shape and geometric correlates of mitral regurgitation one year after surgery. J Thorac Cardiovasc Surg. 2001;121:91-96.
25. Di Donato, M, Dabic, P, Castelvecchio, S, et al. Left ventricular geometry in normal and post-anterior myocardial infarction patients: sphericity index and ‘new’ conicity index comparisons. Eur J Cardiothorac Surg. 2006;29:225-230.
26. Di Donato M, Castelvecchio S, Menicanti L. End-systolic volume following surgical ventricular reconstruction impacts survival in patients with ischemic dilated cardiomyopathy. Eur J Heart Fail. 2010;12:375-381.
27. Dor V, Sabatier M, Montiglio F, et al. Endoventricular patch reconstruction of ischemic failing ventricle. a single center with 20 years experience. advantages of magnetic resonance imaging assessment. Heart Fail Rev. 2004;9:269-286.
28. Elsasser A, Schlepper M, Klovekorn WP, et al. Hibernating myocardium: an incomplete adaptation to ischemia. Circulation. 1997;96:2920-2931.
29. Freeman AP, Walsh WF, Giles RW, et al. Early and long-term results of coronary artery bypass grafting with severely depressed left ventricular performance. Am J Cardiol. 1984;54:749-754.
30. Hüther J, Doens, T, Nitzsche S, et al. Cardiac magnetic resonance imaging for the assessment of ventricular function, geometry, and viability before and after surgical ventricular reconstruction. J Thorac Cardiovasc Surg. 2011;142:1515-1522.
31. Jackson BM, Gorman JH, Moainie SL, et al. Extension of borderzone myocardium in postinfarction dilated cardiomyopathy. J Am Coll Cardiol. 2002;40:1160-1171.
32. Kanzaki H, Bazaz R, Schwartzman D, et al. A mechanism for immediate reduction in mitral regurgitation after cardiac resynchronization therapy. J Am Coll Cardiol. 2004;44:1619-1625.
33. Kawachi K, Kitamura S, Hasegawa J, et al. Increased risk of coronary artery bypass grafting for left ventricular dysfunction with dilated left ventricle. J Cardiovasc Surg. 1997;38:501-505.
34. Kim R, Wu E, Rafael A, et al. The use of contrast-enhanced magnetic resonance imaging to identify reversible myocardial dysfunction. New Engl J Med. 2000;343:1445-1453.
35. Lancelotti P, Zamorano J-L, Vannan M.A. Imaging challenges in secondary mitral regurgitation unsolved issues and perspectives. Circ Cardiovasc Imaging. 2014;7:735-746.
36. Ling LH, Christian TF, Mulvagh SL, et al. Determining myocardial viability in chronic ischemic left ventricular dysfunction: a prospective comparison of rest-redistribution thallium-201 single-photon emission computed tomography, nitroglycerindobutamine echocardiography, and intracoronary myocardial contrast echocardiography. Am Heart J. 2006;151:882-889.
37. Mandegar MH, Yousefnia MA, Roshanali F, et al. Interaction between two predictors of functional outcome after revascularization in ischemic cardiomyopathy: left ventricular volume and amount of viable myocardium. J. Thorac Cardiovasc Surg. 2008;136:930-936.
38. Matsui Y, Fukada Y, Suto Y, et al. Overlapping cardiac volume reduction operation. J Thorac Cardiovasc Surg. 2002;124:395-397.
39. Maxey T, Reece TB, Ellman P, Butler PD. Coronary artery bypass with ventricular restoration is superior to coronary artery bypass alone in patients with ischemic cardiomyopathy. J Thorac Cardiovasc Surg. 2004;127:428-434.
40. Meluzin J, Cerny J, Frelich M, et al. Prognostic value of the amount of dysfunctional but viable myocardium in revascularized patients with coronary artery disease and left ventricular dysfunction. J Amer Coll Cardiology. 1998;32:912-920.
41. Menicanti L, Di Donato M. Surgical left ventricle reconstruction, pathophysiologic insights, results and expectation from the STICH trial. Eur J Cardiothorac Surg. 2004;26:42-47.
42. Nagueh SF, Vaduganathan P, Blaustein A, et al. Identification of hibernating myocardium: comparative accuracy of myocardial contrast echocardiography, rest-redistribution thallium-201 tomography and dobutamine echocardiography. J Am Coll Cardiol. 1997;29 (5):985-993.
43. Oh JK, Velasquez EJ, Menicanti L, et al. Influence of baseline left ventricular function on the clinical outcome of surgical ventricular reconstruction in patients with ischaemic cardiomyopathy. Eur Heart J. 2013;34:39-47.
44. Pagley GA, Beller DD, Watson LW, Gimple M. Improved outcome after coronary bypass surgery in patients with ischemic cardiomyopathy and residual myocardial viability. Circulation. 1997;96:793-800.
45. Pegg TJ, Selvanayagam JB, Jennifer J, et al. Prediction of global left ventricular functional recovery in patients with heart failure undergoing surgical revascularization, based on late gadolinium enhancement cardiovascular magnetic resonance. J Cardiovasc Magn Reson. 2010;12:56.
46. Rahimtoola SH. The hibernating myocardium. Am Heart J. 1989;117:211-221.
47. Ribeiro GA, da Costa CE, Lopes MM, et al. Left ventricular reconstruction benefits patients with ischemic cardiomyopathy and non-viable myocardium. Eur J Cardiothorac Surg. 2006;29:196-201.
48. Schelbert HR, Beanlands R, Bengel F, et al. PET myocardial perfusion and glucose metabolism imaging: Part 2-Guidelines for interpretation and reporting. J Nucl Cardiol. 2003;10:557-571.
49. Schinkel AF, Poldermans В, Rizello V, et al. Why do patients with ischemic cardiomyopathy and a substantial amount of viable myocardium not always recover in function after revascularization? J Thorac Cadiovasc Surgery. 2004;127:385-390.
50. Selvanayagam B, Kardos A, Francis J, et al. Value of delayed-enhancement cardiovascular magnetic resonance imaging in predicting myocardial viability after surgical revascularization. Circulation. 2004;110:1535-1541.
51. Sharir T, Berman DS, Bax J, et al. Prognostic value of stress myocardial perfusion SPECT in patients with markedly reduced left ventricular function. J Nucl Cardiol. 2006;13(4):495-506.
52. Suma H, Isomura T, Horii T, Nomura F. Septal anterior ventricular exclusion procedure for idiopathic dilated cardiomyopathy. Ann Thorac Surg. 2006;82:1344-1348.
53. Takeda K, Matsumiya G, Matsue H, et al. Use of quantitative analysis of remote myocardial fibrosis with delayed-enhancement magnetic resonance imaging to predict outcomes after surgical ventricular restoration for ischemic cardiomyopathy. J Thorac Cardiovasc Surg. 2008;136:1514-1521.
54. White HD, Norris RM, Brown MA, et al. Left ventricular end-systolic volume as the major determinant of survival after recovery from myocardial infarction. Circulation. 1987;76:44-51.
55. Wakasa S, Matsuia Y, Isomurab T, et al. Impact of left ventricular remodelling on outcomes after left ventriculoplasty for ischaemic cardiomyopathy: Japanese surgical ventricular reconstruction group experience. Interact CardioVasc Thorac Surg. 2013;16:785-791.
56. Yamaguchi A, Ino T, Adachi H, et al. Left ventricular volume predicts postoperative course in patients with ischemic cardiomyopathy. Ann Thorac Surg. 1998;65:434-438.
57. Ypenburg C, Lancellotti P, Tops LF, et al. Mechanism of improvement in mitral regurgitation after cardiac resynchronization therapy. Eur Heart J. 2008;29:757-765.